
    
      Test groups: 2 groups (60 subjects/group). 10Pn-PD-DiT group receiving GSK Biologicals'
      10-valent pneumococcal conjugate vaccine + DTPa-HBV-IPV/Hib; Control group receiving Prevenar
      + DTPa-HBV-IPV/Hib
    
  